Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (Rmat) Designation for Descartes-08 for the Treatment of Myasthenia Gravis
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.